Literature DB >> 8670583

Phosphatidyl serine-dependent antiprothrombin antibody is exclusive to patients with lupus anticoagulant.

J Matsuda1, N Saitoh, M Gotoh, K Kawasugi, K Gohchi, M Tsukamoto.   

Abstract

We conducted this study to determine whether antiprothrombin antibody (aPT) [to prothrombin (PT) alone or PT/phosphatidyl serine (PS) complex] actually existed in patients with lupus anticoagulant (LA) and/or anticardiolipin antibody (aCL). aPT to PT alone was positive in 2/7 LA-positive (29%) and 3/7 LA/aCL-positive (43%) patients. aPT to PT/PS complex was positive in 4/7 LA-positive (57%) and 4/7 LA/aCL-positive (57%) patients in the presence of Ca2+. However, none of the aCL-positive patients without LA or the LA/aCL-negative patients were positive for aPT and aPT/PS. Thus, we confirmed the existence of aPT and aPT/PS specifically among LA-positive patients. However, the clinicopathological significance of aPT and aPT/PS in this clinical setting is yet to be clarified.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8670583     DOI: 10.1093/rheumatology/35.6.589

Source DB:  PubMed          Journal:  Br J Rheumatol        ISSN: 0263-7103


  8 in total

1.  Laboratory evaluation of anti-phospholipid syndrome: a preliminary prospective study of phosphatidylserine/prothrombin antibodies in an at-risk patient cohort.

Authors:  N M Heikal; T D Jaskowski; E Malmberg; G Lakos; D W Branch; A E Tebo
Journal:  Clin Exp Immunol       Date:  2015-05       Impact factor: 4.330

Review 2.  How to Identify High-Risk APS Patients: Clinical Utility and Predictive Values of Validated Scores.

Authors:  Kenji Oku; Olga Amengual; Shinsuke Yasuda; Tatsuya Atsumi
Journal:  Curr Rheumatol Rep       Date:  2017-08       Impact factor: 4.592

3.  Utility of antiphosphatidylserine/prothrombin and IgA antiphospholipid assays in systemic lupus erythematosus.

Authors:  Ehtisham Akhter; Zakera Shums; Gary L Norman; Walter Binder; Hong Fang; Michelle Petri
Journal:  J Rheumatol       Date:  2013-02-01       Impact factor: 4.666

Review 4.  Transient antiphospholipid antibodies associated with acute infections in children: a report of three cases and a review of the literature.

Authors:  H Mizumoto; T Maihara; E Hiejima; M Shiota; A Hata; S Seto; T Atsumi; T Koike; D Hata
Journal:  Eur J Pediatr       Date:  2006-03-22       Impact factor: 3.183

5.  Antibodies directed against ribosomal P proteins cross-react with phospholipids.

Authors:  L Caponi; C Anzilotti; G Longombardo; P Migliorini
Journal:  Clin Exp Immunol       Date:  2007-08-03       Impact factor: 4.330

6.  Discovery and characterization of 2 novel subpopulations of aPS/PT antibodies in patients at high risk of thrombosis.

Authors:  Mathivanan Chinnaraj; William Planer; Vittorio Pengo; Nicola Pozzi
Journal:  Blood Adv       Date:  2019-06-11

7.  Reliability of Lupus Anticoagulant and Anti-phosphatidylserine/prothrombin Autoantibodies in Antiphospholipid Syndrome: A Multicenter Study.

Authors:  Savino Sciascia; Massimo Radin; Irene Cecchi; Elena Rubini; Anna Scotta; Roberta Rolla; Barbara Montaruli; Patrizia Pergolini; Giulio Mengozzi; Emanuela Muccini; Simone Baldovino; Michela Ferro; Antonella Vaccarino; Michael Mahler; Elisa Menegatti; Dario Roccatello
Journal:  Front Immunol       Date:  2019-03-05       Impact factor: 7.561

8.  Detection of antiphosphatidylserine/prothrombin antibodies and their potential diagnostic value.

Authors:  Polona Žigon; Saša Čučnik; Aleš Ambrožič; Tanja Kveder; Snežna Sodin Šemrl; Blaž Rozman; Borut Božič
Journal:  Clin Dev Immunol       Date:  2013-09-26
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.